Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Malignant Melanoma

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 21 articles:
HTML format
Text format



Single Articles


    February 2017
  1. ERKES DA, Smith CJ, Wilski NA, Caldeira-Dantas S, et al
    Virus-Specific CD8+ T Cells Infiltrate Melanoma Lesions and Retain Function Independently of PD-1 Expression.
    J Immunol. 2017 Feb 15. pii: 1601064. doi: 10.4049/jimmunol.1601064.
    PubMed     Text format     Abstract available


    January 2017
  2. RAKHMILEVICH AL, Felder M, Lever L, Slowinski J, et al
    Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.
    J Immunol. 2017 Jan 6. pii: 1601255. doi: 10.4049/jimmunol.1601255.
    PubMed     Text format     Abstract available


  3. BALLY AP, Tang Y, Lee JT, Barwick BG, et al
    Conserved Region C Functions To Regulate PD-1 Expression and Subsequent CD8 T Cell Memory.
    J Immunol. 2017;198:205-217.
    PubMed     Text format     Abstract available


    December 2016
  4. NASTI TH, Cochran JB, Vachhani RV, McKay K, et al
    IL-23 Inhibits Melanoma Development by Augmenting DNA Repair and Modulating T Cell Subpopulations.
    J Immunol. 2016 Dec 21. pii: 1601455. doi: 10.4049/jimmunol.1601455.
    PubMed     Text format     Abstract available


  5. WISTUBA-HAMPRECHT K, Martens A, Weide B, Teng KW, et al
    Establishing High Dimensional Immune Signatures from Peripheral Blood via Mass Cytometry in a Discovery Cohort of Stage IV Melanoma Patients.
    J Immunol. 2016 Dec 16. pii: 1600875.
    PubMed     Text format     Abstract available


    July 2016
  6. LIU JQ, Talebian F, Wu L, Liu Z, et al
    A Critical Role for CD200R Signaling in Limiting the Growth and Metastasis of CD200+ Melanoma.
    J Immunol. 2016 Jul 6. pii: 1600052.
    PubMed     Text format     Abstract available


    April 2016
  7. NABIZADEH JA, Manthey HD, Steyn FJ, Chen W, et al
    The Complement C3a Receptor Contributes to Melanoma Tumorigenesis by Inhibiting Neutrophil and CD4+ T Cell Responses.
    J Immunol. 2016 Apr 20. pii: 1600210.
    PubMed     Text format     Abstract available


    March 2016
  8. NOCERA DA, Roselli E, Araya P, Nunez NG, et al
    In Vivo Visualizing the IFN-beta Response Required for Tumor Growth Control in a Therapeutic Model of Polyadenylic-Polyuridylic Acid Administration.
    J Immunol. 2016;196:2860-9.
    PubMed     Text format     Abstract available


    February 2016
  9. BANDYOPADHYAY S, Quinn TJ, Scandiuzzi L, Basu I, et al
    Low-Intensity Focused Ultrasound Induces Reversal of Tumor-Induced T Cell Tolerance and Prevents Immune Escape.
    J Immunol. 2016;196:1964-76.
    PubMed     Text format     Abstract available


  10. FUJII H, Josse J, Tanioka M, Miyachi Y, et al
    Regulatory T Cells in Melanoma Revisited by a Computational Clustering of FOXP3+ T Cell Subpopulations.
    J Immunol. 2016 Feb 10. pii: 1402695.
    PubMed     Text format     Abstract available


    January 2016
  11. ISH-SHALOM E, Meirow Y, Sade-Feldman M, Kanterman J, et al
    Impaired SNX9 Expression in Immune Cells during Chronic Inflammation: Prognostic and Diagnostic Implications.
    J Immunol. 2016;196:156-67.
    PubMed     Text format     Abstract available


  12. TSURUTANI N, Mittal P, St Rose MC, Ngoi SM, et al
    Costimulation Endows Immunotherapeutic CD8 T Cells with IL-36 Responsiveness during Aerobic Glycolysis.
    J Immunol. 2016;196:124-34.
    PubMed     Text format     Abstract available


    November 2015
  13. FONTENEAU JF, Brilot F, Munz C, Gannage M, et al
    The Tumor Antigen NY-ESO-1 Mediates Direct Recognition of Melanoma Cells by CD4+ T Cells after Intercellular Antigen Transfer.
    J Immunol. 2015 Nov 25. pii: 1402664.
    PubMed     Text format     Abstract available


    October 2015
  14. ZHU Z, Cuss SM, Singh V, Gurusamy D, et al
    CD4+ T Cell Help Selectively Enhances High-Avidity Tumor Antigen-Specific CD8+ T Cells.
    J Immunol. 2015;195:3482-9.
    PubMed     Text format     Abstract available


    July 2015
  15. GANNON PO, Wieckowski S, Baumgaertner P, Hebeisen M, et al
    Quantitative TCR:pMHC Dissociation Rate Assessment by NTAmers Reveals Antimelanoma T Cell Repertoires Enriched for High Functional Competence.
    J Immunol. 2015;195:356-66.
    PubMed     Text format     Abstract available


    June 2015
  16. WU MR, Zhang T, Gacerez AT, Coupet TA, et al
    B7H6-Specific Bispecific T Cell Engagers Lead to Tumor Elimination and Host Antitumor Immunity.
    J Immunol. 2015;194:5305-11.
    PubMed     Text format     Abstract available


    May 2015
  17. BRUNO C, Waeckerle-Men Y, Hakerud M, Kundig TM, et al
    Photosensitizer and Light Pave the Way for Cytosolic Targeting and Generation of Cytosolic CD8 T Cells Using PLGA Vaccine Particles.
    J Immunol. 2015 May 27. pii: 1500431.
    PubMed     Text format     Abstract available


  18. ZHANG Y, Chen G, Liu Z, Tian S, et al
    Genetic Vaccines To Potentiate the Effective CD103+ Dendritic Cell-Mediated Cross-Priming of Antitumor Immunity.
    J Immunol. 2015 May 13. pii: 1500089.
    PubMed     Text format     Abstract available


  19. TERHORST D, Fossum E, Baranska A, Tamoutounour S, et al
    Laser-Assisted Intradermal Delivery of Adjuvant-Free Vaccines Targeting XCR1+ Dendritic Cells Induces Potent Antitumoral Responses.
    J Immunol. 2015 May 4. pii: 1500564.
    PubMed     Text format     Abstract available


    April 2015
  20. MONTERO-MELENDEZ T, Gobbetti T, Cooray SN, Jonassen TE, et al
    Biased agonism as a novel strategy to harness the proresolving properties of melanocortin receptors without eliciting melanogenic effects.
    J Immunol. 2015;194:3381-8.
    PubMed     Text format     Abstract available


    January 2015
  21. GAO X, Wang X, Yang Q, Zhao X, et al
    Tumoral expression of IL-33 inhibits tumor growth and modifies the tumor microenvironment through CD8+ T and NK cells.
    J Immunol. 2015;194:438-45.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: